2-Methylthiazolo[4,5-d]pyrimidine | 859796-04-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 2-Methylthiazolo[4,5-d]pyrimidine
• 英文别名: 2-methyl-[1,3]thiazolo[4,5-d]pyrimidine
• CAS: 859796-04-6
• 化学式: C₆H₅N₃S
• 分子量: 151.19
• InChiKey: NAVKNJCPYYUREB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  66.9
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME
  申请人：BlinkBio, Inc.

  公开号：US20170202970A1

  公开（公告）日：2017-07-20

  Described herein are silicon based conjugates capable of delivering one or more payload moieties to a target cell or tissue. Contemplated conjugates may include a silicon-heteroatom core, one or more optional catalytic moieties, a targeting moiety that permits accumulation of the conjugate within a target cell or tissue, one or more payload moieties (e.g., a therapeutic agent or imaging agent), and two or more non-interfering moieties covalently bound to the silicon-heteroatom core.

  本文描述了基于硅的共轭物，能够将一个或多个有效载荷基团传递到靶细胞或组织。考虑到的共轭物可能包括一个硅-杂原子核心，一个或多个可选的催化基团，一个定位基团，允许共轭物在靶细胞或组织内积累，一个或多个有效载荷基团（例如，治疗剂或成像剂），以及与硅-杂原子核心共价结合的两个或更多个不干扰基团。
• New Piperazine Compound and Use Thereof as a HCV Polymerase Inhibitor
  申请人：Abe Hiroyuki

  公开号：US20080081818A1

  公开（公告）日：2008-04-03

  The present invention relates to a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof and an anti-HCV agent and an HCV polymerase inhibitor containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.

  本发明涉及一种由以下式[I]表示的化合物，其中每个符号如规范中定义，或其药学上可接受的盐，或其溶剂化合物，以及含有该化合物的抗HCV剂和HCV聚合酶抑制剂。本发明的化合物基于HCV聚合酶抑制活性显示出抗HCV活性，并且可用作预防或治疗丙型肝炎的药剂。
• Polymerisation Catalyst
  申请人：Gibson Vernon Charles

  公开号：US20080200625A1

  公开（公告）日：2008-08-21

  A polymerisation catalyst comprising (1) a transition metal compound of Formula (A), and optionally (2) an activator, wherein Z is 5-membered heterocyclic containing carbon, nitrogen and at least one other selected from nitrogen, sulphur and oxygen, the remaining atoms in the ring being nitrogen and carbon; M is a metal from Group 3 to 11 or a lanthanide metal; E 1 and E 2 are divalent hydrocarbon, heterocyclic or heterosubstituted derivatives of these; D 1 and D 2 are donor atoms or groups; X is an anionic group, L is a neutral donor group; n=m=zero or 1; y and z are zero or integers so that X and L satisfy the valency/oxidation state of M, characterized in that the complex contains at least one polymerisable olefinic double bond which is present in, or substituent to, at least one of the atoms, groups or ligands represented by Z, E, D and L. The catalyst binds to the forming polymer providing product with good particle morphology.

  一种聚合催化剂，包括（1）式（A）的过渡金属化合物，以及可选的（2）活化剂，其中Z是含有碳、氮和至少一种从氮、硫和氧中选择的其他元素的5元杂环，环中其余原子为氮和碳；M是3到11组或镧系金属中的金属；E1和E2是二价的碳氢化合物、杂环或这些的杂基衍生物；D1和D2是给体原子或基团；X是负离子基团，L是中性给体基团；n=m=0或1；y和z为零或整数，以使X和L满足M的化合价/氧化态，其特征在于该配合物至少含有一个聚合性烯烃双键，该双键存在于Z、E、D和L所代表的原子、基团或配体中的至少一个中或代替其中之一。催化剂与形成的聚合物结合，提供具有良好颗粒形态的产品。
• Diene Polymerisation
  申请人：Jacobsen Grant Berent

  公开号：US20100022724A1

  公开（公告）日：2010-01-28

  A process for producing homopolymers or copolymers of conjugated dienes comprising contacting monomeric material comprising at least one conjugated diene with a catalyst system comprising two or more different transition metal compounds and optionally one or more activators. Preferred transition metal compounds are based on cobalt and chromium, especially complexes thereof having benzimidazole ligands.

  生产共轭二烯的同聚物或共聚物的过程，包括将至少含有一种共轭二烯的单体材料与催化剂体系接触，所述催化剂体系包括两种或更多不同的过渡金属化合物和可选的一个或多个活化剂。首选的过渡金属化合物基于钴和铬，特别是具有苯并咪唑配体的配合物。
• Useful indole compounds
  申请人：Bartolini Wilmin

  公开号：US20070203209A1

  公开（公告）日：2007-08-30

  Indoles having various activities, including indoles that are CRTH2 are described. The compounds are useful for treating asthma, neuropathic pain, allegic rhinitis and other disorders.

  本文描述了具有多种活性的吲哚类化合物，包括CRTH2的吲哚类化合物。这些化合物可用于治疗哮喘、神经病性疼痛、过敏性鼻炎和其他疾病。